CUHK Otto Wong Brain Tumor Centre, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, SAR.
CUHK Otto Wong Brain Tumor Centre, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, SAR.
Asian J Surg. 2018 Sep;41(5):467-472. doi: 10.1016/j.asjsur.2017.06.004. Epub 2017 Aug 26.
5-Aminolevulinic Acid (5-ALA) induced fluorescence is useful in guiding glioma resection. The extent of 5-ALA accumulation is beyond gadolinium contrast enhancement. Supratotal resection may be achieved, potentially granting patients with better survival. We present our experience on 5-ALA guided glioma resection in Chinese ethnics.
Sixteen Patients ingested 5-ALA (Gliolan, Medas Germany) 20 mg/kg·m 4 h before surgery. The tumor resection was guided by fluorescence with neurosurgical microscope. Patient was monitored for general condition, especially for new neurological deficits. Postoperative MRI served as the assessment for extent of resection (EOR).
High grade glioma was confirmed in 12 cases, low grade glioma in three and one inflammation. 5-ALA was used in ten patients with known malignant glioma, and in six patients with presumed diagnosis of malignant glioma. Fifteen cases had positive fluorescence. The intensity was strong in eight and moderate in seven cases. MRI suggested total resection was achieved in 9 patients, near total resection in two and five had subtotal resection. EOR was associated with duration between ingestion of 5-ALA and timing when microscope was brought in for visualization of fluorescence (p = 0.038). Two patients suffered from temporary visual field defects. One patient developed hemiparesis after surgery.
5-ALA is a useful intra-operative guidance for resection. It increases the percentage of total removal of the tumor. It should be used within the window period of the action (4-12 h).
5-氨基酮戊酸(5-ALA)诱导的荧光在指导胶质瘤切除中很有用。5-ALA 的积累程度超过钆对比增强。可以实现超全切除,从而为患者提供更好的生存机会。我们介绍了我们在汉族人群中使用 5-ALA 指导胶质瘤切除的经验。
16 名患者在手术前 4 小时内口服 5-ALA(Gliolan,德国 Medas)20mg/kg·m。荧光显微镜引导肿瘤切除。监测患者的一般情况,特别是新的神经功能缺损。术后 MRI 用于评估切除程度(EOR)。
高级别胶质瘤 12 例,低级别胶质瘤 3 例,炎症 1 例。10 例已知恶性胶质瘤患者使用 5-ALA,6 例疑似恶性胶质瘤患者使用 5-ALA。15 例有阳性荧光。8 例荧光强度强,7 例荧光强度中等。MRI 提示 9 例达到全切除,2 例近全切除,5 例次全切除。EOR 与 5-ALA 摄入与显微镜用于观察荧光之间的时间间隔相关(p=0.038)。2 例患者出现暂时性视野缺损,1 例患者术后出现偏瘫。
5-ALA 是一种有用的术中切除指导方法。它增加了肿瘤全切除的百分比。它应该在作用窗口期(4-12 小时)内使用。